Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Revelation Biosciences Inc (NQ: REVB )

1.080 +0.020 (+1.89%)
Streaming Delayed Price Updated: 3:59 PM EDT, Jun 9, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 350,206
Open 1.040
Bid (Size) 1.050 (10)
Ask (Size) 1.080 (9)
Prev. Close 1.060
Today's Range 0.9843 - 1.110
52wk Range 0.9505 - 67.90
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Recap: Revelation Biosciences Q1 Earnings
 
Via Benzinga
Revelation Biosciences Inc. Announces Financial Results for the Three Months Ended March 31, 2023 and Recent Corporate Progress
From Revelation Biosciences Inc.
Via Business Wire

Performance

YTD
-84.22%
-84.22%
1 Month
-7.69%
-7.69%
3 Month
-37.57%
-37.57%
6 Month
-84.26%
-84.26%
1 Year
-93.57%
-93.57%

More News

Read More
Revelation Biosciences And 2 Other Penny Stocks Insiders Are Buying
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
Via Benzinga
Why Satsuma Pharmaceuticals Shares Are Trading Higher By 94%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Revelation Biosciences Inc. Announces Financial Results for the Three and Twelve Months Ended December 31, 2022 and Recent Corporate Progress
From Revelation Biosciences Inc.
Via Business Wire
Revelation Biosciences Inc. Appoints Dr. Julia Bohannon and Dr. Antonio Hernandez to Scientific Advisory Board
From Revelation Biosciences Inc.
Via Business Wire
Revelation Biosciences Inc. to Participate in a Fireside Chat at the 35th Annual Roth Conference
From Revelation Biosciences Inc.
Via Business Wire
Stocks That Hit 52-Week Lows On Tuesday
Via Benzinga
Revelation Biosciences Inc. Announces Closing of $15.6 Million Public Offering
From Revelation Biosciences Inc.
Via Business Wire
Why Revelation Biosciences Is Trading 40% Lower Thursday
Via Benzinga
US Stocks Turn Lower; Dow Drops 50 Points
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Why Tivic Health Systems Are Trading Lower By 55%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Wall Street Cautiously Optimistic At Midday
Via Talk Markets
Dow Jumps 250 Points; US Jobless Claims Increase Last Week
Via Benzinga
Revelation Biosciences Inc. Announces Pricing of $15.6 Million Public Offering
From Revelation Biosciences Inc.
Via Business Wire
Why Cardiovascular Systems Shares Are Trading Higher By 48%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Via InvestorPlace
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Revelation Biosciences Reveals Encouraging Preclinical Data From Its Lead Fibrosis Candidate
Via Benzinga
Revelation Biosciences Inc. Announces Preclinical Biomarker Data Supporting Activity of REVTx-300
From Revelation Biosciences Inc.
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.